Early enthusiasm for the targeting of tumor cell pHi regulation as an anti-cancer strategy was generated from mutated cells exhibiting exclusively glycolysis or respiration in the presence or absence of NHE1. The gene discussed is SLC9A1; the disease is neoplasm.